Anti-MOG autoantibodies in Italian multiple sclerosis patients: Specificity, sensitivity and clinical association

International Immunology

Volumn 16, Issue 4, 2004, Pages 559-565

  Mantegazza, Renato ^a   Cristaldini, Piercarlo ^a   Bernasconi, Pia ^a   Baggi, Fulvio ^a   Pedotti, Rosetta ^a   Piccini, Ilaria ^a   Mascoli, Nerina ^a   La Mantia, Loredana ^b   Antozzi, Carlo ^a   Simoncini, Ornella ^a   Cornelio, Ferdinando ^a   Milanese, Clara ^b  

^a Immunol and Muscular Pathology Unit   (Italy)

^b Multiple Sclerosis Center   (Italy)

Author keywords

Antibody; Antibody index; Autoimmunity; Multiple sclerosis; Myelin oligodendrocyte glycoprotein

Indexed keywords

AUTOANTIBODY; ENCEPHALITOGENIC PROTEIN; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN PROTEIN; PROTEIN ANTIBODY; PROTEOLIPID PROTEIN;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMYELINATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOMODULATION; INFLAMMATORY CELL; ITALY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYELIN SHEATH; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RELAPSE; SENSITIVITY AND SPECIFICITY; SEROLOGY;

ADULT; ANALYSIS OF VARIANCE; AUTOANTIBODIES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; BLOTTING, WESTERN; CENTRAL NERVOUS SYSTEM DISEASES; DISABILITY EVALUATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; ITALY; LINEAR MODELS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; MYELIN-ASSOCIATED GLYCOPROTEIN; OLIGOCLONAL BANDS; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; SPINE;

EID: 11144358095     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxh056     Document Type: Article

References (40)

1. Neuhaus, O., Archelos, J. J. and Hartung, H. P. 2003. Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection. Trends Pharmacol. Sci. 24:131.
2. Storch, M. K., Stefferl, A., Brehm, U., Weissert, R., Wallstrom, E., Kerschensteiner, M., Olsson, T., Linington, C. and Lassmann, H. 1998. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol. 8:681.
3. Genain, C. P., Cannella, B., Hauser, S. L. and Raine, C. S. 1999. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5:170.
4. Lucchinetti, C. F., Bruck, W., Rodriguez, M. and Lassmann, H. 1996. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol. 6:259.
5. Cross, A. H., Trotter, J. L. and Lyons, J. 2001. B cells and antibodies in CNS demyelinating disease. J. Neuroimmunol. 112:1.
6. Archelos, J. J., Storch, M. K. and Hartung, H. P. 2000. The role of B cells and autoantibodies in multiple sclerosis. Ann. Neurol. 47:694.
7. Iglesias, A., Bauer, J., Litzenburger, T., Schubart, A. and Linington, C. 2001. T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia 36:220.
8. Linington, C., Bradl, M., Lassmann, H., Brunner, C. and Vass, K. 1988. Augmentation of demyelinating in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am. J. Pathol. 130:443.
9. Olsson, T., Baig, S., Hojeberg, B. and Link, H. 1990. Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis. Ann. Neurol. 27:132.
10. Sun, J., Link, H., Olsson, T., Xiao, B. G., Andersson, G., Ekre, H. P., Linington, C. and Diener, P. 1991. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J. Immunol. 146:1490.
11. Xiao, B. G., Linington, C. and Link, H. 1991. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J. Neuroimmunol. 31:91.
12. Cruz, M., Olsson, T., Ernerudh, J., Hojeberg, B. and Link, H. 1987. Immunoblot detection of oligoclonal anti-myelin basic protein IgG antibodies in cerebrospinal fluid in multiple sclerosis. Neurology 37:1515.
13. Martino, G., Olsson, T., Fredrikson, S., Hojeberg, B., Kostulas, V., Grimaldi, L. M. and Link, H. 1991. Cells producing antibodies specific for myelin basic protein region 70-89 are predominant in cerebrospinal fluid from patients with multiple sclerosis. Eur. J. Immunol. 21:2971.
14. Reindl, M., Linington, C., Brehm, U., Egg, R., Dilitz, E., Deisenhammer, F., Poewe, W. and Berger, T. 1999. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Brain 122:2047.
15. Brokstad, K. A., Page, M., Nyland, H. and Haaheim, L. R. 1994. Autoantibodies to myelin basic protein are not present in the serum and CSF of MS patients. Acta Neurol. Scand. 89:407.
16. Archelos, J. J., Trotter, J., Previtali, S., Weissbrich, B., Toyka, K. V. and Hartung, H. P. 1998. Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosis. Ann. Neurol. 43:15.
17. Morris, M. M., Piddlesden, S., Groome, N. and Amor, S. 1997. Anti-myelin antibodies modulate experimental allergic encephalomyelitis in Biozzi ABH mice. Biochem. Soc. Trans. 25:168S.
18. Lublin, F. D. and Reingold, S. C. 1996. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46:907.
19. Kurtzke, J. F. 1983. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444.
20. Link, H. and Tibbling, G. 1977. Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand. J. Clin. Lab. Invest. 37:397.
21. Reiber, H. and Peter, J. B. 2001. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J. Neurol. Sci. 184:101.
22. Hilton, A. A., Slavin, A. J., Hilton, D. J. and Bernard, C. C. A. 1995. Characterization of cDNA and genomic clones encoding human myelin oligodendrocyte glycoprotein. J. Neurochem. 65:309.
23. Bettadapura, J., Menon, K. K., Moritz, S., Liu, J. and Bernard, C. C. A. 1998. Expression, purification, and encephalitogenicity of recombinant human myelin oligodendrocyte glycoprotein. J. Neurochem. 70:1593.
24. Baggi, F., Andreetta, F., Antozzi, C., Simoncini, O., Confalonieri, P., Labeit, S., Cornelio, F. and Mantegazza, R. 1998. Anti-titin and anti-ryanodine receptor antibodies in myasthenia gravis patients with thymoma. Ann. NY Acad. Sci. 841:538.
25. Noseworthy, J. H., Lucchinetti, C., Rodriguez, M. and Weinshenker, B. G. 2000. Multiple sclerosis. N. Engl. J. Med. 343:938.
26. Brunner, C., Lassmann, H., Waehneldt, T. V., Matthieu, J. M. and Linington, C. 1989. Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2′,3′-cyclic nucleotide 3′-phosphodiesterase in the CNS of adult rats. J. Neurochem. 52:296.
27. Gardinier, M. V., Amiguet, P., Linington, C. and Matthieu, J. M. 1992. Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily. J. Neurosci. Res. 33:177.
28. della Gaspera, B., Pham-Dinh, D., Roussel, G., Nussbaum, J. L. and Dautigny, A. 1998. Membrane topology of the myelin/oligodendrocyte glycoprotein. Eur. J. Biochem. 258:478.
29. Kerlero de Rosbo, N., Honegger, P., Lassmann, H. and Matthieu, J. M. 1990. Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin/oligodendrocyte glycoprotein. J. Neurochem. 55:583.
30. Lassmann, H., Brunner, C., Bradl, M. and Linington, C. 1988. Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol. (Berl.) 75:566.
31. Schluesener, H. J., Sobel, R. A., Linington, C. and Weiner, H. L. 1987. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 139:4016.
32. Adelmann, M., Wood, J., Benzel, I., Fiori, P., Lassmann, H., Matthieu, J. M., Gardinier, M. V., Dornmair, K. and Linington, C. 1995. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J. Neuroimmunol. 63:17.
33. Genain, C. P., Nguyen, M. H., Letvin, N. L., Pearl, R., Davis, R. L., Adelman, M., Lees, M. B., Linington, C. and Hauser, S. L. 1995. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J. Clin. Invest. 96:2966.
34. Karni, A., Bakimer-Kleiner, R., Abramsky, O. and Ben-Nun, A. 1999. Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis. Arch. Neurol. 56:311.
35. Egg, R., Reindl, M., Deisenhammer, F., Linington, C. and Berger, T. 2001. Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis. Mult. Scler. 7:285.
36. Lindert, R. B., Haase, C. G., Brehm, U., Linington, C., Wekerle, H. and Hohlfeld, R. 1999. Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein. Brain 122:2089.
37. Haase, C. G., Guggenmos, J., Brehm, U., Andersson, M., Olsson, T., Reindl, M., Schneidewind, J. M., Zettl, U. K., Heidenreich, F., Berger, T., Wekerle, H., Hohlfeld, R. and Linington, C. 2001. The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls. J. Neuroimmunol. 114:220.
38. De March, A. K., De Bouwerie, M., Kolopp-Sarda, M. N., Faure, G. C., Béné, M. C. and Bernard, C. C. A. 2003. Anti-myelin oligodendrocyte glycoprotein B-cell responses in multiple sclerosis. J. Neuroimmunol. 135:117.
39. Berger, T., Rubner, P., Schautzer, F., Egg, R., Ulmer, H., Mayringer, I., Dilitz, E., Deisenhammer, F. and Reindl, M. 2003. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N. Engl. J. Med. 349:139.
40. Mazzucco, S., Mata, S., Vergelli, M., Fioresi, R., Nardi, E., Mazzanti, B., Chelli, M., Lolli, F., Ginanneschi, M., Pinto, F., Massacesi, L. and Papini, A. M. 1999. A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases. Bioorg. Med. Chem. Lett. 9:167.